Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
Mouse Polyclonal (IgG) to Human NTF3 / Neurotrophin 3
Human, Mouse, Rat
Western blot, ELISA
Rabbit Polyclonal (IgG) to Human NTF3 / Neurotrophin 3
Human, Mouse, Rat
IHC, Western blot
Human NTF3 / Neurotrophin 3
Human, Mouse, Rat (tested or 100% immunogen sequence identity)
Specificity and Use
Synthetic peptide from mature human NT3 (Neurotrophin-3, NT-3) conjugated to an immunogenic carrier protein. The peptide is homologous in many other species including rat and mouse.
Specific for mature NT-3.
IHC: Antigen retrieval is essential for use on paraffin sections.
Lyophilized. Centrifuge to remove any insoluble material
500 µl Sterile water
Maintain lyophilized and reconstituted antibodies at -20°C for long term storage and at 2-8°C for a shorter term. When reconstituting, glycerol (1:1) may be added for an additional stability. Avoid freeze/thaw cycles.
NTF3 / Neurotrophin 3 is a member of the neurotrophin family, that controls survival and differentiation of mammalian neurons. This protein is closely related to both nerve growth factor and brain-derived neurotrophic factor. It may be involved in the maintenance of the adult nervous system, and may affect development of neurons in the embryo when it is expressed in human placenta. NTF3-deficient mice generated by gene targeting display severe movement defects of the limbs.